Kathy Davy, MBA, is vice president and general manager of Clinical Sequencing Solutions at Thermo Fisher Scientific. She completed her BS in biology from the University of California, Irvine, and holds an MBA from The Fuqua School of Business at Duke University.
High throughput, reliability, sensitivity, and accuracy make NGS a robust reproductive health tool
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
